Streptomyces as Potential Synthetic Polymer Degraders: A Systematic Review

The inherent resistance of synthetic plastics to degradation has led to an increasing challenge of waste accumulation problem and created a pollution issue that can only be addressed with novel complementary methods such as biodegradation. Since biocontrol is a promising eco-friendly option to address this challenge, the identification of suitable biological agents is a crucial requirement. Among the existing options, organisms of the Streptomyces genus have been reported to biodegrade several complex polymeric macromolecules such as chitin, lignin, and cellulose. Therefore, this systematic review aimed to evaluate the potential of Streptomyces strains for the biodegradation of synthetic plastics. The results showed that although Streptomyces strains are widely distributed in different ecosystems in nature, few studies have explored their capacity as degraders of synthetic polymers. Moreover, most of the research in this field has focused on Streptomyces strains with promising biotransforming potential against polyethylene-like polymers. Our findings suggest that this field of study is still in the early stages of development. Moreover, considering the diverse ecological niches associated with Streptomyces, these actinobacteria could serve as complementary agents for plastic waste management and thereby enhance carbon cycle dynamics.

Species of Fungi and Pollen in the PM1 and the Inhalable Fraction of Indoor Air in Homes

Airborne microbial fragments in the PM1 fraction (particles with aerodynamic diameters less than 1 µm) are a cause for concern as they may potentially deposit in the alveoli of the human airways. This study aimed to use qPCR to identify and quantify 24 different species or groups of genera in the PM1 and the inhalation fraction (particles that may enter the mouth or nose during breathing) of indoor air and to relate this to what has previously been found for each species. Results showed that eight fungal species, and Aspergillus/Penicillium/Paecilomyces variotii, as well as Alnus/Corylus and actinobacteria belonging to the Streptomyces genus were detected both in the PM1 and the inhalable fraction. Five fungal species were only detected in the inhalable fraction. A significant effect of season was found on the fungal composition in the PM1 (p = 0.001) and the inhalable (p = 0.017) fraction. This study demonstrated that it is possible to use qPCR to identify and quantify different microbes in the PM1 fraction, and it has improved our understanding of the qualitative and quantitative relationship between the PM1 and the inhalable microbial particles in indoor air. Combined with the literature review it also shows a large variation within and between species in the share of fungi which is present as fragments.

Molecular and biological characteristics of streptomyces diversity in the soils of the Saxaul forest in Mongolia

Saxaul (Haloxylon ammodendron) is a plant with a wide ecological range that forms forests in Mongolia often used as pastures for camels. Actinomycetes were isolated from the soils of the saxaul forest using selective isolation methods. According to the results of phylogenetic analysis based on the sequences of the 16S rRNA gene fragment, it has been established that the obtained isolates belong to the Streptomyces genus. According to the taxonomic position, strains (M41; M42; M 43; C 4-46; C 4-47; C 4-50; M44; C 5-54; C5-60 and C 5-63) demonstrate a high level of similarity (99.20- 100 %) of 16S rRNA gene sequences with type strains of the following species: S. fradiae, S. huasconensis, S. coeruleoprunus, S. tendae, S. rubrogriseus, S. malachitofuscus, S. flavoviridis S. pilosus, S. caelestis, S. azureus, S. fulvissimus, S. microflavus, S. griseussubsp. griseus, S. anulatus, S. cyaneofuscatus, S. luridiscabiei, S. halstedii, S. fulvorobeus, S. pratensis, S. setonii, S. anulatus, S. pratensis, S. caelestis and S. azureus.

Actinomycetes as the basis of Probiotics for Plants

The present review describes the concept of probiotics for plants and analyzes the prospects for using actinomycetes as producers of these drugs. The minimum requirements for plant probiotic microorganisms are proposed, similar to those for human probiotic microorganisms. These are utility, efficiency and safety for plants, as well as mandatory isolation from plant samples. It is noted that these requirements are usually met by endophytic and rhizosphere microorganisms that stimulate plant growth and provide them with protection from phytopathogens. Evidence is given for the possibility of attributing actinomycetes to probiotic plant bacteria, due to the close relationship of these microorganisms with plants, their wide distribution in populations of endophytic and rhizosphere microorganisms, and the presence of phytoregulatory activity. The review provides examples of genera and species of actinomycetes that are promising producers of probiotics for agronomically important crops. The most studied and commercialized of them are representatives of the Streptomyces genus. The current state, prospects and problems in commercialization of probiotics based on actinomycetes are discussed. probiotic microorganisms of plants, associative actinomycetes, endophytes, rhizosphere, biological preparations

A Preliminary Investigation on the In-Vitro Antibacterial Activities of Cave Actinomycetes

Actinomycetes are prolific producers of secondary metabolites majority of which have phenomenal industrial applications. Actinomycetes recovered from cave habitats have generated a considerable interest among the scientific community with respect to their adaptability under such unique environmental conditions. Garhwal Himalaya, Uttarakhand abodes several pristine caves which have not been previously explored for the presence of actinomycetes. The present study has been undertaken to assess the in vitro antibacterial properties of actinomycetes recovered from some of the caves located in Garhwal Himalayan region. In the present study, a total of 127 actinomycetes were isolated from three distinct caves. Majority of the isolates exhibited antibacterial activity against gram-positive bacteria. Actinomycetes isolates RCM1 and SCMM1 were observed to evince promising antibacterial activities. Members of Streptomyces genus were found to be predominant in all the samples.

Morphological Differentiation of Streptomyces clavuligerus Exposed to Diverse Environmental Conditions and Its Relationship with Clavulanic Acid Biosynthesis

Clavulanic acid (CA) is a potent inhibitor of class A β-lactamase enzymes produced by Streptomyces clavuligerus (S. clavuligerus) as a defense mechanism. Due to its industrial interest, the process optimization is under continuous investigation. This work aimed at identifying the potential relationship that might exist between S. clavuligerus ATCC 27064 morphology and CA biosynthesis. For this, modified culture conditions such as source, size, and age of inoculum, culture media, and geometry of fermentation flasks were tested. We observed that high density spore suspensions (1 × 107 spores/mL) represent the best inoculum source for S. clavuligerus cell suspension culture. Further, we studied the life cycle of S. clavuligerus in liquid medium, using optic, confocal, and electron microscopy; results allowed us to observe a potential relationship that might exist between the accumulation of CA and the morphology of disperse hyphae. Reactor geometries that increase shear stress promote smaller pellets and a quick disintegration of these in dispersed secondary mycelia, which begins the pseudosporulation process, thus easing CA accumulation. These outcomes greatly contribute to improving the understanding of antibiotic biosynthesis in the Streptomyces genus.

Molecular Identification of Selected Streptomyces Strains Isolated from Mexican Tropical Soils and their Anti-Candida Activity

The increasing incidence of Candida albicans infections and resistance to current antifungal therapies has led to the search for new and more effective antifungal compounds. Actinobacterial species from the Streptomyces genus are recognized as some of the major producers of antimicrobial compounds. Therefore, the aims of this study were: (1) the identification of Streptomyces strains isolated from Mexican tropical acidic soils, (2) the evaluation of their antifungal activity on C. albicans, and (3) the exploration of the presence of polyketide synthase genes in their genome and antifungal secondary metabolites in their extracts. Four actinobacterial strains, isolated from previously unexplored soils with antibacterial antecedents, were selected. These strains were identified as Streptomyces angustmyceticus S6A-03, Streptomyces manipurensis S3A-05 and S3A-09, and Streptomyces parvisporogenes S2A-04, according to their molecular analyses. The ethanol extract of the lyophilized supernatant of S. parvisporogenes displayed the most interesting antifungal activity against C. albicans, with a minimum inhibitory concentration (MIC) of 0.5 mg/mL. Type I polyketide synthase (PKS-I) and non-ribosomal peptide synthase (NRPS) genes were detected in all strains. In addition, type II PKS genes (PKS-II) were also found in S. manipurensis S3A-05 and S. parvisporogenes. LC-UV-HRMS analysis of the active organic extract of S. parvisporogenes indicated the presence of the known antifungal compound carbazomycin G as the major component.

Production of β-Lactamase Inhibitors by Streptomyces Species

β-Lactamase inhibitors have emerged as an effective alternative to reduce the effects of resistance against β-lactam antibiotics. The Streptomyces genus is known for being an exceptional natural source of antimicrobials and β-lactamase inhibitors such as clavulanic acid, which is largely applied in clinical practice. To protect against the increasing prevalence of multidrug-resistant bacterial strains, new antibiotics and β-lactamase inhibitors need to be discovered and developed. This review will cover an update about the main β-lactamase inhibitors producers belonging to the Streptomyces genus; advanced methods, such as genetic and metabolic engineering, to enhance inhibitor production compared with wild-type strains; and fermentation and purification processes. Moreover, clinical practice and commercial issues are discussed. The commitment of companies and governments to develop innovative strategies and methods to improve the access to new, efficient, and potentially cost-effective microbial products to combat the antimicrobial resistance is also highlighted.